Search research articles
Contact Us
Filters
Showing results (11-20 of 301) with videos related to
Page
of 31
Sort By:
Gynecologic Oncology
|
September 27, 2017
Primum non nocere: Are we ready for POLE testing in endometrial cancer?
Casey M Cosgrove, David E Cohn, Paul J Goodfellow
Gynecologic Oncology
|
September 9, 2010
Immunization with synthetic VEGF peptides in ovarian cancer
Bing Wang, Pravin T P Kaumaya, David E Cohn
Gynecologic Oncology
|
December 21, 2016
Bokhman Redux: Endometrial cancer "types" in the 21st century
Adrian A Suarez, Ashley S Felix, David E Cohn
Gynecologic Oncology
|
January 30, 2010
Lymphadenectomy for endometrial cancer: the controversy
Leigh G Seamon, Jeffrey M Fowler, David E Cohn
Gynecologic Oncology Reports
|
June 30, 2016
Aspirin and endometrial cancer risk
Theodore M Brasky, David E Cohn, Brittany M Bernardo
Gynecologic Oncology
|
March 30, 2004
The role of MRI in the conservative management of endometrial cancer
Inbar Ben-Shachar, Kenneth M Vitellas, David E Cohn
Nature Reviews. Clinical Oncology
|
June 30, 2009
Role of lymphadenectomy in the staging of endometrial cancer
Kimberly E Resnick, David E Cohn, Jeffrey M Fowler
Gynecologic Oncology
|
December 8, 2006
Vaginal evisceration during intraperitoneal chemotherapy for advanced ovarian cancer
Amy M Burkett, David E Cohn, Larry J Copeland
Obstetrics and Gynecology
|
August 2, 2008
Robotic trocar site small bowel evisceration after gynecologic cancer surgery
Leigh G Seamon, Floor Backes, Kimberly Resnick, et al.
Gynecologic Oncology
|
April 21, 2009
Current and emerging trends in Lynch syndrome identification in women with endometrial cancer
Kimberly E Resnick, Heather Hampel, Richard Fishel, et al.
Page
of 31
Search research articles
Search
Showing results (11-20 of 301) with videos related to
Sort By:
Page
of 31
Gynecologic Oncology
|
September 27, 2017
Primum non nocere: Are we ready for POLE testing in endometrial cancer?
Casey M Cosgrove, David E Cohn, Paul J Goodfellow
Gynecologic Oncology
|
September 9, 2010
Immunization with synthetic VEGF peptides in ovarian cancer
Bing Wang, Pravin T P Kaumaya, David E Cohn
Gynecologic Oncology
|
December 21, 2016
Bokhman Redux: Endometrial cancer "types" in the 21st century
Adrian A Suarez, Ashley S Felix, David E Cohn
Gynecologic Oncology
|
January 30, 2010
Lymphadenectomy for endometrial cancer: the controversy
Leigh G Seamon, Jeffrey M Fowler, David E Cohn
Gynecologic Oncology Reports
|
June 30, 2016
Aspirin and endometrial cancer risk
Theodore M Brasky, David E Cohn, Brittany M Bernardo
Gynecologic Oncology
|
March 30, 2004
The role of MRI in the conservative management of endometrial cancer
Inbar Ben-Shachar, Kenneth M Vitellas, David E Cohn
Nature Reviews. Clinical Oncology
|
June 30, 2009
Role of lymphadenectomy in the staging of endometrial cancer
Kimberly E Resnick, David E Cohn, Jeffrey M Fowler
Gynecologic Oncology
|
December 8, 2006
Vaginal evisceration during intraperitoneal chemotherapy for advanced ovarian cancer
Amy M Burkett, David E Cohn, Larry J Copeland
Obstetrics and Gynecology
|
August 2, 2008
Robotic trocar site small bowel evisceration after gynecologic cancer surgery
Leigh G Seamon, Floor Backes, Kimberly Resnick, et al.
Gynecologic Oncology
|
April 21, 2009
Current and emerging trends in Lynch syndrome identification in women with endometrial cancer
Kimberly E Resnick, Heather Hampel, Richard Fishel, et al.
Page
of 31